According to reports from The Economic Times, Edelweiss Alternatives Asset Advisors (EAAA) has successfully secured commitments of more than ₹1,200 crore for its second Discovery Fund. The growth fund, which is registered as a Category II Alternative Investment Fund with Sebi, achieved its first close at ₹800 crore in March and has since crossed the ₹1,200 crore milestone in total commitments. The fund is positioned to write cheques of approximately ₹200 crore per company for its investments.
As reported by The Hindu BusinessLine, Arboreal Bio Innovations has successfully raised ₹230 crore in a Series A funding round led by Edelweiss Alternatives Asset Advisors (EAAA). The funding round also included participation from Omnivore and continued backing from existing investor Rainmatter by Zerodha. The fresh capital will be utilized to expand manufacturing capacity, strengthen research and development capabilities, and accelerate the commercialisation of next-generation functional ingredients. This investment represents the fund's maiden investment from the new vehicle and demonstrates the fund's focus on backing businesses with category leader potential.
According to The Hindu BusinessLine, Arboreal Bio Innovations has built a differentiated "contextual innovation" model focused on developing ingredient solutions for specific nutritional, functional, sensory and commercial requirements of Indian consumers and brands. The company's integrated ingredient technology platform has supported more than 300 product launches across over 1,100 consumer brands and nutraceutical manufacturers during the past 18 months. Arboreal has developed and commercialised proprietary ingredients across next-generation proteins, cocoa-based ingredients, natural zero-calorie sweeteners and functional fibres, with several additional ingredient platforms currently under development.
As reported by The Hindu BusinessLine, Swati Pandey, Co-Founder and CEO of Arboreal Bio Innovations, emphasized that the fundraise validates the company's mission of building clean, science-led solutions addressing global nutritional challenges. Manish Chauhan, Co-Founder and COO, highlighted that the investment validates both the platform's strength and upcoming opportunities, enabling deeper investment in science, manufacturing, talent and long-term innovation. Ashish Agarwal, Managing Director of Private Equity at EAAA, noted that the investment reflects the fund's strategy of backing businesses with category leader potential, particularly excited about Arboreal's next-generation yeast protein products.
